SCIENTIFIC REVIEW OF THE YEAR BREAST CANCER Session 1: December 7th 2020 14:30 – 17:15 CET / 15:30 – 18:15 EET, Virtual Meeting
00:00:00
Program
To enter the online Scientific Exchange Meeting, please enter the access data, which were sent to your email.
@
Email Password
This is an AstraZeneca organised and funded non-promotional scientific exchange meeting.
ENTER In case of technical problems contact us: mobile: +420 602 700 601, e-mail: office@coll.cz Breastcancer2020.online uses cookies and other technologies to analyze user activity. For additional details, refer to our Cookie Policy.
Veeva ID: CZ-1942
Date of preparation: December 2020
SCIENTIFIC REVIEW OF THE YEAR BREAST CANCER Session 1: December 7th 2020 14:30 – 17:15 CET / 15:30 – 18:15 EET, Virtual Meeting
00:00:00
Program
Statements of fact and opinions expressed are those of the speakers individually, and, unless expressly stated to the contrary, are not the opinion or position of AstraZeneca. AstraZeneca does not endorse or approve, and assumes no responsibility for, the content, accuracy or completeness of the information presented and discussed.
The information provided here is for the purpose of scientific medical exchange meeting only.
We look forward to your active participation in the Scientific Exchange Meeting via CHAT bellow. Please share with us your comments, remarks, personal experience and also questions. All chat posts will be published on an ongoing basis. Please specify if your question or comment is intended for a specific topic or speaker.
Do you have a question? Veeva ID: CZ-1942
Date of preparation: December 2020
Click here to chat with us!
ONLINE - Click here to chat
SCIENTIFIC REVIEW OF THE YEAR BREAST CANCER Session 1: December 7th 2020 14:30 – 17:15 CET / 15:30 – 18:15 EET, Virtual Meeting
PROGRAM AstraZeneca Welcome Gabriela Teodorescu AstraZeneca Medical Director CEE-BA / Helena Pikartová AstraZeneca Medical Director Onco & Regulatory CZ/SK Chairman Assoc. Prof. Ruppert Bartsch, MD (Austria) Introduction Section 1: Early Breast Cancer Assoc. Prof. Alinta Hegmane, MD, PhD. (Latvia) Neoadjuvant treatment Dr. Simona Borštnar, MD, PhD (Slovenia) Adjuvant treatment Discussion Section 2: Metastatic Breast Cancer Assoc. Prof. MUDr. Patrik Palacka, MD, PhD., MPH (Slovakia) First and second line treatment Dr. Mircea Dediu (Romania) mBC – later lines of treatment Discussion Section 3: Diagnostics of Breast Cancer: Co-operation in Tumorboard Prim. MUDr. Katarína Petráková, PhD. (Czech Republic) Prof. MUDr. Aleš Ryška, Ph.D. (Czech Republic) Discussion Chairman Assoc. Prof. Ruppert Bartsch, MD (Austria) Conclusion
LIVE STREAM Veeva ID: CZ-1942
Date of preparation: December 2020